Apomorphine hydrochloride - Parkinson's disease
You are here : Home > Formulary Search > Apomorphine hydrochloride - Parkinson's disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Amber
Formulations :
- Pre-filled syringe
- Subcutaneous infusion
- Subcutaneous injection (sc)
Formulary Status :
Restrictions / Comments :
Important
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
Documentation
PAD Profile
ChemicalSubstance :
Apomorphine hydrochloride
Indication :
Parkinson's disease
Group Name :
Keywords :
PD, shared care
Brand Names Include :
Apo-go, Dacepton, Apo-Go POD
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) have reviewed and agreed the updated apomorphine AMBER shared care document.
Other Indications
Below are listed other indications that Apomorphine hydrochloride is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Parkinson's disease.
- Amantadine hydrochloride
- Bromocriptine
- Cabergoline
- Clonazepam
- Co-beneldopa
- Co-careldopa
- Entacapone
- Foslevodopa with foscarbidopa
- Levodopa
- Levodopa with carbidopa and entacapone
- Melatonin
- Opicapone
- Orphenadrine hydrochloride
- Pergolide mesilate
- Pramipexole
- Procyclidine hydrochloride
- Rasagiline mesilate
- Ropinirole hydrochloride
- Rotigotine
- Safinamide
- Selegiline hydrochloride
- Tolcapone
- Trihexyphenidyl hydrochloride